نتائج البحث - "Griškevicius, Laimonas"

1

كتاب

Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival

المؤلفون: Tettero, Jesse M., Ngai, Lok Lam, Bachas, Costa, Breems, Dimitri A., Fischer, Thomas, Gjertsen, Bjorn T., Gradowska, Patrycja, Griskevicius, Laimonas, Janssen, Jeroen J. W. M., Juliusson, Gunnar, Maertens, Johan, Manz, Markus G., Pabst, Thomas, Passweg, Jakob, Porkka, Kimmo, Valk, Peter J. M., Loewenberg, Bob, Ossenkoppele, Gert J., Cloos, Jacqueline

المساهمون: Clinicum, Department of Oncology, HUS Comprehensive Cancer Center

مصطلحات موضوعية: Adults, Aml, Younger, 3122 Cancers

وصف الملف: application/pdf

العلاقة: Funding This study was supported by the Dutch Cancer Society (n. ALPE-2013-6371) .; Tettero , J M , Ngai , L L , Bachas , C , Breems , D A , Fischer , T , Gjertsen , B T , Gradowska , P , Griskevicius , L , Janssen , J J W M , Juliusson , G , Maertens , J , Manz , M G , Pabst , T , Passweg , J , Porkka , K , Valk , P J M , Loewenberg , B , Ossenkoppele , G J & Cloos , J 2023 , ' Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival ' , Haematologica , vol. 108 , no. 10 , pp. 2794-2798 . https://doi.org/10.3324/haematol.2022.282639Test; ORCID: /0000-0003-4112-5902/work/151223205; 211f6b86-d382-44a9-b093-d2f05703d778; http://hdl.handle.net/10138/569758Test; 001109389400023

الإتاحة: http://hdl.handle.net/10138/569758Test

View record in BASE

2

دورية أكاديمية

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin

المؤلفون: Baron, Frederic, Galimard, Jacques-Emmanuel, Labopin, Myriam, Yakoub-Agha, Ibrahim, Niittyvuopio, Riitta, Kroger, Nicolaus, Griskevicius, Laimonas, Wu, Depei, Forcade, Edouard, Richard, Carlos, Aljurf, Mahmoud, Helbig, Grzegorz, Labussiere-Wallet, Helene, Mohty, Mohamad, Nagler, Arnon

المساهمون: Université Pierre et Marie Curie - Paris 6 UPMC, Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286

وصف الملف: application/octet-stream

العلاقة: Haematologica; http://hdl.handle.net/20.500.12210/104855Test

الإتاحة: https://doi.org/20.500.12210/104855Test
https://hdl.handle.net/20.500.12210/104855Test

View record in BASE

3

دورية أكاديمية

Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

المؤلفون: Dam, Merete Eybye, Lynggaard, Line Stensig, Hansen, Stefan Nygaard, Schmiegelow, Kjeld, Centanni, Daniel, Centanni, Maddalena, Friberg, Lena, Karlsson, Mats, Wik, Hilde, Johannsdottir, Inga, Malmros, Johan, Vaitkeviciene, Goda, Griskevicius , Laimonas, Hallböök, Helene, Jónsson, Ólafur Gísli, Overgaard, Ulrik Malthe, Heyman, Mats, Albertsen, BK

المصدر: Dam , M E , Lynggaard , L S , Hansen , S N , Schmiegelow , K , Centanni , D , Centanni , M , Friberg , L , Karlsson , M , Wik , H , Johannsdottir , I , Malmros , J , Vaitkeviciene , G , Griskevicius , L , Hallböök , H , Jónsson , Ó G , Overgaard , U M , Heyman , M & Albertsen , BK 2024 , ' Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia ' , Leukemia , pp. ....

العلاقة: https://pure.au.dk/portal/en/publications/4716cff1-e9c3-429e-92ec-aaac57065fadTest

الإتاحة: https://doi.org/10.1038/s41375-024-02153-6Test
https://pure.au.dk/portal/en/publications/4716cff1-e9c3-429e-92ec-aaac57065fadTest

View record in BASE

4

دورية أكاديمية

Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT).

المصدر: Transplantation and Cellular Therapy, 30, 93.e1 - 93.e12 (2024)

مصطلحات موضوعية: Allogeneic hematopoietic cell transplantation, Chronic myeloid leukemia, Haploidentical donor, Post-transplantation cyclophosphamide, Unrelated donor, Cyclophosphamide, Adult, Humans, Chronic Disease, Cyclophosphamide/therapeutic use, Retrospective Studies, Unrelated Donors, Graft vs Host Disease/prevention & control, Hematopoietic Stem Cell Transplantation/adverse effects, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy, Myeloid, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, BCR-ABL Positive, Immunology and Allergy, Molecular Medicine, Hematology, Cell Biology, Transplantation, Human health sciences, Sciences de la santé humaine, Hématologie

العلاقة: https://api.elsevier.com/content/article/PII:S2666636723015737?httpAccept=text/xmlTest; urn:issn:2666-6375; urn:issn:2666-6367; https://orbi.uliege.be/handle/2268/313455Test; info:hdl:2268/313455; https://orbi.uliege.be/bitstream/2268/313455/1/509.pdfTest; scopus-id:2-s2.0-85175423281; info:pmid:37783337

الإتاحة: https://doi.org/10.1016/j.jtct.2023.09.019Test
https://orbi.uliege.be/handle/2268/313455Test
https://orbi.uliege.be/bitstream/2268/313455/1/509.pdfTest

View record in BASE

5

مؤتمر

Azacitidine in combination with 14-day venetoclax versus azacitidine monotherapy for myelodysplastic syndrome with increased blasts-2 in clinical practice setting /

المؤلفون: Žučenka, Andrius, Čepulytė, Rūta, Davainienė, Birutė, Vasilevska, Dominika, Pileckytė, Regina, Trociukas, Igoris, Pečeliūnas, Valdas, Griškevičius, Laimonas

المصدر: HemaSphere: 28th Congress of the European Hematology Association EHA2023, June 8 - 15, Frankfurt, 2023 : abstract book., Philadelphia : Wolters Kluwer Health, Inc., 2023, vol. 7, suppl. 3, art. no. PB2005, p. 3860-3861. ; eISSN 2572-9241

مصطلحات موضوعية: azacitidine, venetoclax, allogeneic hematopoietic stem cell transplant, myelodysplastic syndrome

وصف الملف: application/pdf

العلاقة: https://epublications.vu.lt/object/elaba:175413557/175413557.pdfTest; https://repository.vu.lt/VU:ELABAPDB175413557&prefLang=en_USTest

الإتاحة: https://doi.org/10.1097/01.HS9.0000974836.00135.eaTest
https://repository.vu.lt/VU:ELABAPDB175413557&prefLang=en_USTest

View record in BASE

6

مؤتمر

Gilteritinib maintenance after allogeneic stem cell transplantation for FLT3 mutated acute myeloid leukemia /

المؤلفون: Žučenka, Andrius, Vasilevska, Dominika, Daukėlaitė, Guoda, Trociukas, Igoris, Pečeliūnas, Valdas, Pileckytė, Regina, Griškevičius, Laimonas

المصدر: HemaSphere: 28th Congress of the European Hematology Association EHA2023, June 8 - 15, Frankfurt, 2023 : abstract book., Philadelphia : Ovid Technologies (Wolters Kluwer Health), 2023, vol. 7, suppl. 3, p. 1013-1014. ; eISSN 2572-9241

مصطلحات موضوعية: AML, Allo-SCT, FLT3, maintenance

وصف الملف: application/pdf

العلاقة: https://epublications.vu.lt/object/elaba:174478713/174478713.pdfTest; https://repository.vu.lt/VU:ELABAPDB174478713&prefLang=en_USTest

الإتاحة: https://doi.org/10.1097/01.HS9.0000969204.07443.aaTest
https://repository.vu.lt/VU:ELABAPDB174478713&prefLang=en_USTest

View record in BASE